In-Vitro Diagnostics Market Global Briefing 2018

In Vitro Diagnostics Market Global Briefing 2018 Including: Molecular Diagnostics, Point-of-Care Diagnostics, Immunochemistry, Microbiology, Hematology and Immunohematology Covering: Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Sysmex Corporation

Feb 2018

Reasons to Purchase • Get up to date information available on the market globally.

• Identify growth segments and opportunities.

• Facilitate decision making on the basis of historic (2013-17) and forecast (2017-21) data and understand the drivers and restraints on the market.

• Develop strategies based on likely future developments.

• Gain a global perspective on the development of the market.

Scope Markets Covered: Point-of-Care Diagnostics; Immunochemistry; Clinical Chemistry;

Molecular Diagnostics; Microbiology; Hemostasis; Hematology; Immunohematology Companies Mentioned: Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Sysmex Corporation Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa Time series: Five years historic (2013-17) and forecast (2017-21).

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

In-Vitro Diagnostics Market Characteristics In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorporated in in-vitro diagnostics are polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. In-vitro diagnostic medical devices include reagents, reagent products, control materials, calibration materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine test strips, blood sugar monitoring systems for diabetics and receptacles for medical specimens.

The segments that are covered include – Point-of-Care Diagnostics – Immunochemistry – Clinical Chemistry – Molecular Diagnostics – Microbiology; Hemostasis – Hematology; Immunohematology –

In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included.

The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.

In-Vitro Diagnostics Market Historic Growth The global in-vitro diagnostics market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%.

The chart and table below shows the year-on-year growth of the global in-vitro diagnostics market during 2013 – 2017.

Drivers of the Market:

Restraints on the Market:

In-Vitro Diagnostics Market Forecast Growth The global in-vitro diagnostics market grew from $X billion in 2017 to $X billion in 2021 at a compound annual growth rate (CAGR) of X%.

The chart and table below shows the year-on-year growth of the global in-vitro diagnostics market during 2017 - 2021.

Drivers of the Market:

Restraints on the Market:

In-Vitro Diagnostics Market Segmentation The chart and table below shows the split of the in-vitro diagnostics market in 2017.

The total market value for in-vitro diagnostics was $X billion in 2017. The markets that are covered include Point-of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology; Immunohematology.

Point-of-Care Diagnostics was the x largest segment in the in-vitro diagnostics market with X% share of the market. The market value for the point-of-care diagnostics was $x billion in 2017.

Immunochemistry made up around X% share of the market. The market value for the immunochemistry was $x billion in 2017.

In-Vitro Diagnostics Market Regional And Country Analysis The Asia Pacific was the largest region in the in-vitro diagnostics market in 2017, invitro diagnostics for $X billion or X% market share.

North America was the x largest region in-vitro diagnostics for $X billion or X% market share.

Western Europe was the x largest region in-vitro diagnostics for $X billion or X% market share.

In-Vitro Diagnostics Market Competitive Landscape The leading competitors in the global in-vitro diagnostics market are Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Sysmex Corporation.

The chart and table below displays the percentage market share of the top players in the in-vitro diagnostics market industry.

Company Profile Siemens Healthineers Overview Products and Services Strategy Financial Performance

Abbott Laboratories Inc. Overview Products and Services Strategy Financial Performance Thermo Fisher Scientific Inc. Overview Products and Services Strategy Financial Performance

Sysmex Corporation Overview Products and Services Strategy Financial Performance